The combination of endoscopic retrograde cholangiopancreatography (ERCP) with tumour markers (Ca 19-9 and CEA) improves the diagnostic accuracy and sensitivity of PC from pseudo-tumour-like pancreatitis, thereby lowering the rate of a missed diagnosis of PC [44]. The gene discussed is CEACAM5; the disease is pancreatitis.